BioCentury
ARTICLE | Financial News

arGEN-X completes venture financing

September 14, 2009 7:00 AM UTC

arGEN-X B.V., Rotterdam, the Netherlands Business: Antibodies Date completed: 9/10/09 Type: Venture financing Raised: €9.5 million ($13.6 million) Investors: Forbion Capital Partners; Life Sciences Pa...